INOpulse Devices for PAH Disorders Evaluated in Clinical Trials
COPD, Idiopathic Pulmonary Fibrosis, News, Pulmonary Hypertension
Bellerophon Therapeutics recently enrolled the first participants in the Phase 3 INOvation-1 clinical trial intended to test the efficiency and safety of INOpulse for the treatment of pulmonary arterial hypertension (PAH). ... Read more